So we just inferred from the experimental results that DSC2 suppressed the nuclear translocation and transcriptional activity of γ-catenin, then inhibited the growth of GC through downregulating the expression of BCL-2 and inhibiting the P53/PTEN/PI3K/AKT signaling pathway, respectively. The gene discussed is DSC2; the disease is gastric cancer.